These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1086514)

  • 21. Humoral and cell-mediated immunity in neonates with herpes simplex virus infection.
    Sullender WM; Miller JL; Yasukawa LL; Bradley JS; Black SB; Yeager AS; Arvin AM
    J Infect Dis; 1987 Jan; 155(1):28-37. PubMed ID: 3025306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions of T-and B-lymphocytes and macrophages in recovery from virus infections.
    Allison AC
    Proc R Soc Med; 1973 Dec; 66(12):1151-4. PubMed ID: 4599617
    [No Abstract]   [Full Text] [Related]  

  • 23. Specific cell-mediated immunity and infections with herpes viruses in cardiac transplant recipients.
    Pollard RB; Arvin AM; Gamberg P; Rand KH; Gallagher JG; Merigan TC
    Am J Med; 1982 Nov; 73(5):679-87. PubMed ID: 6291387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human peripheral null lymphocytes. II. Producers of type-1 interferon upon stimulation with tumor cells, Herpes simplex virus and Corynebacterium parvum.
    Peter HH; Dallügge H; Zawatzky R; Euler S; Leibold W; Kirchner H
    Eur J Immunol; 1980 Jul; 10(7):547-55. PubMed ID: 6157543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental infection of inbred mice with herpes simplex virus type 1. I. Investigation of humoral and cellular immunity and of interferon induction.
    Zawatzky R; Hilfenhaus J; Marcucci F; Kirchner H
    J Gen Virol; 1981 Mar; 53(Pt 1):31-8. PubMed ID: 6168735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunity to herpes simplex virus type 2. IV. Impaired lymphokine production during recrudescence correlates with an imbalance in T lymphocyte subsets.
    Sheridan JF; Donnenberg AD; Aurelian L; Elpern DJ
    J Immunol; 1982 Jul; 129(1):326-31. PubMed ID: 7045224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunological investigations in recurrent herpes simplex (author's transl)].
    Simon M; Djawari D
    Z Hautkr; 1982 Jun; 57(12):879-83. PubMed ID: 6981262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunity to herpes simplex virus type 2. V. Risk of recurrent disease following primary infection: modulation of T-cell subsets and lymphokine (LIF) production.
    Sheridan JF; Aurelian L
    Diagn Immunol; 1983; 1(3):245-56. PubMed ID: 6209056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Host defences in mice against infections with herpes simplex virus.
    Mogensen SC
    Microbiol Sci; 1984 Aug; 1(5):127-30. PubMed ID: 6086079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Herpes simplex virus immunology: problems, progress, and promises.
    Kohl S
    J Infect Dis; 1985 Sep; 152(3):435-40. PubMed ID: 2993439
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of antibody in in vitro stimulation of lymphocytes.
    Kapoor AK; Khan IU; Bhushan V
    Indian J Exp Biol; 1983 Nov; 21(11):583-4. PubMed ID: 6327508
    [No Abstract]   [Full Text] [Related]  

  • 32. Susceptibility of human lymphocyte populations to infection by herpes simplex virus.
    Pelton BK; Imrie RC; Denman AM
    Immunology; 1977 May; 32(5):803-10. PubMed ID: 301117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An in vitro study of depressed cell-mediated immunity and of T and B lymphocytes in atopic dermatitis.
    Hovmark A
    Acta Derm Venereol; 1977; 57(3):237-42. PubMed ID: 71829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-mediated immunity in mice with primary, secondary and latent herpes simplex virus infection.
    Darville JM; Blyth WA
    Arch Virol; 1982; 74(2-3):135-44. PubMed ID: 6299234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-mediated cytotoxicity against virus-infected target cells in humans. II. Interferon induction and activation of natural killer cells.
    Santoli D; Trinchieri G; Koprowski H
    J Immunol; 1978 Aug; 121(2):532-8. PubMed ID: 150448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Specific protective immune mechanism in herpes simplex virus infection].
    Otani T; Mori R
    Uirusu; 1986 Dec; 36(2):221-32. PubMed ID: 3031876
    [No Abstract]   [Full Text] [Related]  

  • 37. Cytotoxic properties of human monocyte-macrophages for human fibroblasts infected in herpes simplex virus: interferon production and augmentation.
    Stanwick TL; Campbell DE; Nahmias AJ
    Cell Immunol; 1982 Jun; 70(1):132-47. PubMed ID: 6180837
    [No Abstract]   [Full Text] [Related]  

  • 38. Suppression by progesterone of nonspecific in vitro lymphocyte stimulation in mice as a mechanism for the enhancement of herpes simplex virus type 2 vaginal infection.
    Baker DA; Phillips CA; Roessner K; Albertini RJ; Mann LI
    Am J Obstet Gynecol; 1980 Feb; 136(4):440-5. PubMed ID: 6243861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell-mediated immune responses in patients with recurrent Herpes Simplex infections. II. Infection-associated deficiency of lymphokine production in patients with recurrent herpes labialis or herpes progenitalis.
    O'Reilly RJ; Chibbaro A; Anger E; Lopez C
    J Immunol; 1977 Mar; 118(3):1095-1102. PubMed ID: 191524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of the immune and interferon status of children infected with herpes simplex virus and living in areas with increased radiation background].
    Alimbarova LM; Sokha LG; Baleva LS; Lavrukhina LA; Barinskiĭ IF
    Vopr Virusol; 1997; 42(1):36-41. PubMed ID: 9103044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.